View drug registration information details.
Items | Registration information |
ID | 2037 |
No | 2037 |
Brand Name | CEFO - L 100 MG |
Ingredients | CEFIXIME TRIHYDRATE USP 114.24 MG EQ.TO CEFIXIME ANHYDROUS 100 MG, LACTIC ACID BACILLUS 60 MILLION SPORES 35 MG |
Dosage Form | TABLET |
Primary Packaging | ALU-ALU BLISTERPACK |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | RESPIRATORY TRACT INFECTIONS, OTITIS MEDIA, SEQUENTIAL TREATMENT AFTER INITIAL I.V. CHEMOTHERAPY AFTER PARENTERAL CEPHALOSPORIN, URINARY TRACT INFECTIONS, GONORRHOEA, TYPHOID FEVER. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | YELLOW COLORED, CIRCULAR, FLAT BEVELED EDGED, UNCOATED TABLET HAVING PLAIN ON ONE SIDE & BREAK LINE ON OTHER SIDE |
Note | |
License Owner | PALAMY PHARMA CO., LTD |
Manufacturer | MEDLEY PHARMACEUTICALS LTD. |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 07 I 3144/08 |
FDD Registration Date | 2-Feb-2023 |
Expiry Date | 01-Feb-2026 |
Back to drug list
|